UNIVERSITY OF ARIZONA
A role for pharmaceutical control of protease-activated receptor-2 for the treatment of asthma
A role for pharmaceutical control of protease-activated receptor-2 for the treatment of asthma is a funding opportunity from UNIVERSITY OF ARIZONA, up to 761371, closing May 31, 2029.
May 31, 2029
(1035d left)Overview
PROJECT ABSTRACT Asthma is a heterogenous disease that impacts ~10% of the US population. It presents as a syndrome of non- specific airway hyperresponsiveness, inflammation and intermittent respiratory symptoms. Even though more than half of patients receiving standard asthma medication remain uncontrolled, mainstay…